First Manhattan
ALXN

First Manhattan’s Alexion Pharmaceuticals ALXN Stock Holding History

First Manhattan’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-250
Closed -$45K – 1746
2021
Q2 		$45K Sell
250
-100
-29% -$17.2K ﹤0.01% 1007
2021
Q1 		$53K Hold
350
– – ﹤0.01% 953
2020
Q4 		$54K Hold
350
– – ﹤0.01% 891
2020
Q3 		$40K Hold
350
– – ﹤0.01% 917
2020
Q2 		$39K Hold
350
– – ﹤0.01% 923
2020
Q1 		$31K Sell
350
-375
-52% -$36.8K ﹤0.01% 940
2019
Q4 		$78K Buy
725
+625
+625% +$66.8K ﹤0.01% 830
2019
Q3 		$9K Buy
+100
New +$11.3K ﹤0.01% 1168
2018
Q1 		– Sell
-690
Closed -$82K – 1493
2017
Q4 		$82K Buy
+690
New +$84K ﹤0.01% 895
2015
Q1 		– Sell
-19
Closed -$3K – 1536
2014
Q4 		$3K Buy
+19
New +$3.52K ﹤0.01% 1390

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return